Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Anticoagulation for Catheter-related Thrombosis in Cancer Patients
NCT04256525Phase 4Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- May 2020
- Primary completion
- Aug 2021
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin, rivaroxaban, low molecular weight heparin calcium in catheter-related thrombosis (CRT), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Status: unknown.
02
Drugs
aspirinrivaroxabanlow molecular weight heparin calcium
03
Conditions
catheter-related thrombosis (CRT)
Beyond the preview
Go deeper on NCT04256525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04256525.